• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM Back to Search Results
Model Number S-50-080-120-P6
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 06/19/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).Evaluation summary: visual inspection was performed on the returned device.The reported deployment issue was unable to be confirmed as the stent had already been fully deployed.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot revealed no other incidents.It should be noted that the supera instruction for use (ifu) instructs: while maintaining increased magnification from step 3, rotate the deployment lock to the unlocked position.Under fluoroscopy, slowly advance the thumb slide to the distal most position on the handle.Confirm under fluoroscopy that the entire supera stent has emerged from the outer sheath and is released.The investigation was unable to determine a cause for the reported difficulty.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event or Problem Description
It was reported that the procedure was to treat a lesion located in the popliteal artery that was heavily tortuous.Following pre-dilatation, a supera peripheral self expanding stent (ses) 5.0 x 80 6f 120 cm was deployed.It was thought that the entire stent had completely come out of the sheath, however it did not detach and when the deployment system was removed from the anatomy, the stent came with it.It was reported that the delivery system was not removed under fluoroscopy.Another supera ses was used to complete the procedure.There was no reported adverse patient effect.There was no reported clinically significant delay in the procedure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Common Device Name
SELF EXPANDING STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key6714410
Report Number2024168-2017-05899
Device Sequence Number919849
Product Code NIP
UDI-Device Identifier08717648211751
UDI-Public(01)08717648211751(17)180930(10)6102061
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P120020
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date (Section B) 07/14/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2018
Device Model NumberS-50-080-120-P6
Device Catalogue NumberS-50-080-120-P6
Device Lot Number6102061
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/30/2017
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/21/2017
Initial Report FDA Received Date07/14/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-